Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.

Komrokji RS, Bennett JM.

Curr Hematol Rep. 2005 May;4(3):175-81. Review.

PMID:
15865868
2.

Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classification.

Komrokji RS, Bennett JM.

Curr Hematol Malig Rep. 2006 Mar;1(1):9-15. doi: 10.1007/s11899-006-0011-x. Review.

PMID:
20425325
3.

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.

Bennett JM, Komrokji RS.

Hematology. 2005;10 Suppl 1:258-69. Review.

PMID:
16188686
4.

The myelodysplastic syndromes: classification and prognosis.

Komrokji R, Bennett JM.

Curr Hematol Rep. 2003 May;2(3):179-85. Review.

PMID:
12901338
5.
6.

A comparative review of classification systems in myelodysplastic syndromes (MDS).

Bennett JM.

Semin Oncol. 2005 Aug;32(4 Suppl 5):S3-10. Review.

PMID:
16085011
7.

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M.

Blood. 2001 Nov 15;98(10):2935-41.

8.

The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey.

Demirkan F, Alacacioglu I, Piskin O, Ozsan HG, Akinci B, Ozcan AM, Yavuzsen T, Yuksel E, Undar B.

Leuk Lymphoma. 2007 Jul;48(7):1372-8.

PMID:
17613766
9.

Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.

Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.

Leuk Res. 2006 Aug;30(8):971-7. Epub 2006 Jan 19.

PMID:
16423393
10.

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ.

Hematol J. 2002;3(3):137-44.

PMID:
12111649
11.

[New WHO classification of myelodysplastic syndromes. The consequences].

Ugo V.

Pathol Biol (Paris). 2002 May;50(4):278-82. Review. French.

PMID:
12085674
12.

[Myelodysplastic syndromes in adults].

Beyne-Rauzy O, Laurent G, Adoue D.

Presse Med. 2007 Mar;36(3 Pt 2):481-91. Epub 2006 Dec 15. Review. French.

PMID:
17336857
13.

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.

Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C.

Br J Haematol. 2007 May;137(3):193-205.

PMID:
17408458
14.
15.

Detection of risk groups in myelodysplastic syndromes. A multicenter study.

Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, García J, Flores G, Goldztein S, Larripa I.

Haematologica. 2002 Jan;87(1):9-16.

16.

Evolving classifications of the myelodysplastic syndromes.

Komrokji RS, Bennett JM.

Curr Opin Hematol. 2007 Mar;14(2):98-105. Review.

PMID:
17255786
17.

The WHO classification of the myelodysplastic syndromes.

Bain B.

Exp Oncol. 2004 Sep;26(3):166-9.

PMID:
15494682
18.

The classification of MDS: from FAB to WHO and beyond.

Vardiman J.

Leuk Res. 2012 Dec;36(12):1453-8. doi: 10.1016/j.leukres.2012.08.008. Epub 2012 Aug 30. Review.

PMID:
22940257
19.

Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes.

Breccia M, Carmosino I, Biondo F, Mancini M, Russo E, Latagliata R, Alimena G.

Leuk Res. 2006 Feb;30(2):178-82. Epub 2005 Aug 15.

PMID:
16102825
20.
Items per page

Supplemental Content

Write to the Help Desk